Latest Financial Guidance News

Page 4 of 29
Bridge SaaS Limited has exited its non-core investment in Brightside Disability Support, recouping its initial outlay and sharpening its focus on AI-driven disability services and robotics innovation.
Ada Torres
Ada Torres
13 July 2026
Bravura Solutions maintains FY26 revenue guidance while raising cash EBITDA expectations to $77 million, driven by robust project services demand and disciplined cost management.
Sophie Babbage
Sophie Babbage
10 July 2026
Mayfield Childcare has pulled its FY26 earnings guidance amid rising costs and regulatory shifts, while cautiously advancing its Mayfield 360 allied health initiative.
Victor Sage
Victor Sage
10 July 2026
Jumbo Interactive updates its FY26 earnings outlook, trimming EBITDA guidance for its UK acquisition while significantly upgrading US business forecasts, amid ongoing integration and leadership changes.
Sophie Babbage
Sophie Babbage
9 July 2026
Qoria Limited marked a turning point in FY25, delivering 25% growth in Annual Recurring Revenue and a 684% jump in underlying EBITDA, setting sights on 20% EBITDA margin in FY26 amid global digital safety expansion.
Sophie Babbage
Sophie Babbage
8 July 2026
Orezone Gold outlines 2026 production and cost outlook for its newly acquired Casa Berardi mine, highlighting a transitional phase with higher costs and planned exploration ramp-up.
Maxwell Dee
Maxwell Dee
8 July 2026
Promisia Healthcare’s aged care occupancy climbed to a record 96% in June 2026, underpinning its FY27 earnings growth guidance. Aldwins House led the turnaround, while solar initiatives and wellness programs roll out across sites.
Ada Torres
Ada Torres
7 July 2026
Atomos Limited has trimmed its FY26 sales guidance to approximately $40 million due to softer end-consumer demand and delayed product shipments, while forecasting EBITDA between $2.5 million and $3.5 million supported by improved margins.
Sophie Babbage
Sophie Babbage
6 July 2026
Telix Pharmaceuticals has gained FDA alignment to advance Part 2 of its ProstACT Global Phase 3 trial for TLX591-Tx in metastatic castration-resistant prostate cancer, setting the stage for U.S. enrolment pending regulatory approval.
Ada Torres
Ada Torres
2 July 2026
ACDC Metals has locked in a crucial 10-year Retention Licence for its Goschen Central rare earth and heavy mineral sands project, underpinning long-term development plans backed by a robust $384 million NPV8 Scoping Study.
Maxwell Dee
Maxwell Dee
1 July 2026
Comms Group Limited is set to divest its onPlatinum division for $30 million, aiming to strengthen its balance sheet and return capital to shareholders. The company maintains solid FY26 guidance, driven by organic growth and cost rationalisation.
Victor Sage
Victor Sage
1 July 2026
Alcidion confirms FY26 revenue above $50 million and EBITDA over $5 million, completing the Kyra flow products acquisition from Telstra Health to expand its patient flow solutions in ANZ and the UK.
Ada Torres
Ada Torres
29 June 2026

Browse the archive

Full archive